Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| PLYX | Polaryx Therapeutics | $5.98 | $2.46 | 69.89% | 21.7M | $167M | $2.20$48.91 |
| ATPC | Agape Atp | $3.36 | $1.34 | 66.34% | 1.1M | $2.0M | $1.72$128.25 |
| ACXP | Acurx Pharmaceuticals | $2.88 | $0.93 | 47.32% | 30.3M | $5.0M | $1.33$21.00 |
| MGNX | MacroGenics | $3.34 | $0.98 | 41.52% | 439K | $149M | $0.99$3.50 |
| BUUU | Buuu Group | $17.65 | $4.39 | 33.11% | 28.6K | $221M | $3.67$20.76 |
| PIII | P3 Health Partners | $3.80 | $0.92 | 31.72% | 841.9K | $9.5M | $1.52$11.30 |
| INKT | MiNK Therapeutics | $13.44 | $2.99 | 28.61% | 243.8K | $49M | $6.34$76.00 |
| OCC | Optical Cable | $7.72 | $1.61 | 26.33% | 711.6K | $54M | $2.40$11.50 |
| BIRD | Allbirds | $3.91 | $0.80 | 25.72% | 3K | $26M | $2.40$12.85 |
| LFMD | LifeMD | $3.92 | $0.80 | 25.64% | 142.8K | $150M | $2.56$15.84 |
| CRMU | Themes ETF Trust - Leverage Shares 2x Long Crml Daily ETF | $9.44 | $1.84 | 24.26% | 66.5K | - | $6.52$15.25 |
| ZNTL | Zentalis Pharmaceuticals | $3.05 | $0.57 | 22.78% | 1.8M | $179M | $1.01$3.95 |
| TTEC | TTEC Holdings | $3.03 | $0.54 | 21.49% | 78.4K | $121M | $1.98$5.60 |
| ZVRA | Zevra Therapeutics | $11.08 | $1.96 | 21.44% | 281.9K | $513M | $6.19$13.16 |
| CVV | Cvd Equipment | $4.69 | $0.82 | 21.19% | 105.6K | $27M | $2.46$5.86 |
| TKNO | Alpha Teknova | $2.56 | $0.44 | 20.52% | 306.6K | $114M | $1.91$7.48 |
| TENX | Tenax Therapeutics | $13.28 | $2.26 | 20.51% | 29.6K | $69M | $4.63$18.38 |
| VYGR | Voyager Therapeutics | $4.94 | $0.83 | 20.20% | 129.2K | $229M | $2.65$5.55 |
| FGI | Fgi Industries | $4.10 | $0.69 | 20.16% | 18.7K | $6.5M | $2.28$12.62 |
| FIGR | Figure Technology Solutions | $38.84 | $6.20 | 18.98% | 26.7M | $7.0B | $25.00$78.00 |
| SEV | Aptera Motors | $3.75 | $0.59 | 18.51% | 883.1K | $103M | $1.29$40.85 |
| LFS | Leifras | $2.68 | $0.41 | 18.06% | 188.8K | $59M | $1.58$12.49 |
| IXHL | Incannex Healthcare | $4.99 | $0.76 | 17.97% | 35.2K | $49M | $2.40$49.80 |
| QTTB | Q32 Bio | $6.00 | $0.90 | 17.65% | 388.3K | $66M | $1.35$6.37 |
| UECG | Themes ETF Trust - Leverage Shares 2x Long Uec Daily ETF | $10.60 | $1.52 | 16.75% | 39.1K | - | $7.57$15.46 |
| FCUV | Focus Universal | $5.01 | $0.65 | 14.91% | 14.9K | $4.3M | $4.13$61.40 |
| APPX | Investment Managers Series Trust II - Tradr 2x Long App Daily ETF | $40.39 | -$7.76 | -16.11% | 805.3K | - | $20.21$157.62 |
| HSPTU | Horizon Space Acquisition II Corp. | $7.24 | -$4.37 | -37.64% | 34 | $66M | $7.24$13.50 |
Related Articles
Featured Article
2 Biotech Stocks That Could Make You Richer
James Halley|Jul 14, 2023
These biotech companies are seeing a spike in revenue growth.
3 Growth Stocks You Can Buy Right Now With Less Than $100
Rick Munarriz|Nov 23, 2022
You don't need a lot money to buy into these fallen -- but not broken -- growth stocks. One has plummeted 97% this year.
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Keith Speights|Mar 19, 2022
Voyager Therapeutics has promising technology. But the stock is very risky.
Why Allbirds Stock Should Be on Your Watchlist
Trevor Jennewine|Nov 24, 2021
This newly public company makes high-tech shoes.
Parkinson's Disease Patients Get Long-Term Benefits From Experimental Gene Therapy
Cory Renauer|Sep 11, 2020
Three years after treatment with NBIb-1817, Parkinson's disease patients still are still showing improvements.
Is It Too Late to Jump In on Zentalis?
James Halley|Jun 3, 2020
The company's share price has nearly tripled since its IPO less than two months ago. Is it too late to get in on the fun?
Is Now a Good Time To Buy Neurocrine Biosciences?
James Halley|May 14, 2020
The biopharmaceutical company has seen shares rise 44.5% in less than two months.
3 Small-Cap Biotech Stocks That Surged Last Week
Cory Renauer|May 11, 2020
Here's what's behind their impressive market performances.
These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?
David Haen|Apr 23, 2020
These companies just raised significant cash to advance promising drug pipelines.
4 Stocks Battling Breast Cancer
David Haen|Oct 26, 2019
With Breast Cancer Awareness Month drawing to a close and the San Antonio Breast Cancer Symposium on the horizon, stay alert for breaking news from companies developing new treatments.
